Eye surgery

U.S. IDE Trial Results for Glaukos’ iStent infinite™ Show Substantial Reduction in IOP

Retrieved on: 
Mercoledì, Gennaio 13, 2021
Health, Medical devices, Surgery, Clinical trials, Pharmaceutical, Optical, Biotechnology, Hypotension, Glaucoma, Eye surgery, Minimally invasive glaucoma surgery

In the trial, 72 subjects were implanted with the iStent infinite at 15 separate clinical sites.

Key Points: 
  • In the trial, 72 subjects were implanted with the iStent infinite at 15 separate clinical sites.
  • Patients entered the iStent infinite IDE pivotal study with a mean baseline IOP of 23.4 mmHg on an average of 3.1 medications and an average of 2 failed prior surgeries.
  • At 12 months, 76% of subjects achieved 20% or greater reduction in mean diurnal IOP from baseline on the same or lower ocular hypotensive medication burden.
  • We are excited to announce this strong pivotal data highlighting the favorable safety and effectiveness of the iStent infinite.

Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.

Retrieved on: 
Giovedì, Gennaio 7, 2021
Health, Optical, Surgery, Medical specialties, Clinical medicine, Vision, Eye surgery, Medicine, Eye, Ophthalmology, Corrective lenses, Intraocular lens, Cataract surgery, Cataract, Posterior chamber of eyeball

This new presbyopia-mitigating lens is now available to all U.S. ophthalmologists for patients undergoing cataract surgery.

Key Points: 
  • This new presbyopia-mitigating lens is now available to all U.S. ophthalmologists for patients undergoing cataract surgery.
  • A cataract is a cloudy area in the natural lens of the eye that affects vision.
  • The non-diffractive AcrySof IQ VivityTM Extended Vision Posterior Chamber Intraocular Lens Model DFT015 (referred to as AcrySof IQ VivityTM IOL) is a UV-absorbing and blue light filtering foldable intraocular lens (IOL).
  • Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict.

Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Markets, 2020-2024 - Increasing Medical Tourism for LASIK Surgery Driving Market Growth - ResearchAndMarkets.com

Retrieved on: 
Mercoledì, Gennaio 6, 2021
Biotechnology, Optical, Health, Medical devices, Eye surgery, LASIK, Keratomileusis, Ron Link, Stephen Slade

The report on laser-assisted in-situ keratomileusis (LASIK) surgery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

Key Points: 
  • The report on laser-assisted in-situ keratomileusis (LASIK) surgery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The laser-assisted in-situ keratomileusis (LASIK) surgery market analysis includes technology segment, end-user segment and geographical landscapes.
  • This study identifies the increasing medical tourism for LASIK surgery as one of the prime reasons driving the laser-assisted in-situ keratomileusis (LASIK) surgery market growth during the next few years.
  • Also, the laser-assisted in-situ keratomileusis (LASIK) surgery market analysis report includes information on upcoming trends and challenges that will influence market growth.

Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market Research 2020-2024 | Post-Pandemic Industry Planning Structure by Technavio

Retrieved on: 
Lunedì, Dicembre 28, 2020
Surgery, Health, Other Technology, Technology, Optical, Eye surgery, LASIK, Keratomileusis, Ron Link, Stephen Slade

View the full release here: https://www.businesswire.com/news/home/20201228005136/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201228005136/en/
    Technavio has announced its latest market research report titled Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market 2020-2024 (Graphic: Business Wire)
    Worried about the impact of COVID-19 on your business?
  • The report on the laser-assisted in-situ keratomileusis (LASIK) surgery market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The laser-assisted in-situ keratomileusis (LASIK) surgery market analysis includes technology, end-user, and geography landscape.
  • This study identifies the increasing medical tourism for LASIK surgery as one of the prime reasons driving the laser-assisted in-situ keratomileusis (LASIK) surgery market growth during the next few years.

Worldwide Retinal Surgery Devices Industry to 2025 - Players Include Alcon, Bausch & Lomb Incorporated & Carl Zeiss

Retrieved on: 
Lunedì, Dicembre 14, 2020
Clinical medicine, Medicine, Ophthalmology, Eye surgery, Retinal detachment, Vitrectomy, Retina, Surgery

The global retinal surgery devices market is currently witnessing strong growth.

Key Points: 
  • The global retinal surgery devices market is currently witnessing strong growth.
  • Retinal surgery devices refer to various equipment and accessories used for surgically repairing torn or detached retinas.
  • Vitrectomy machines, scissors, lasers, tamponades, probes and light pipes are the most commonly used retinal surgery devices.
  • What is the structure of the global retinal surgery devices market and who are the key players?

The Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market is expected to grow by $ 375.04 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period

Retrieved on: 
Lunedì, Dicembre 14, 2020
Eye surgery, LASIK, Keratomileusis, Ron Link, Stephen Slade

The analyst has been monitoring the laser-assisted in-situ keratomileusis (LASIK) surgery market and it is poised to grow by $ 375.04 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period.

Key Points: 
  • The analyst has been monitoring the laser-assisted in-situ keratomileusis (LASIK) surgery market and it is poised to grow by $ 375.04 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period.
  • Our report on laser-assisted in-situ keratomileusis (LASIK) surgery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The laser-assisted in-situ keratomileusis (LASIK) surgery market analysis includes technology segment, end-user segment and geographical landscapes.
  • The laser-assisted in-situ keratomileusis (LASIK) surgery market is segmented as below:

Global Corneal Endothelial Dystrophy (CED) Epidemiology Forecast Report 2017-2020 & 2030 - ResearchAndMarkets.com

Retrieved on: 
Venerdì, Dicembre 4, 2020
Health, Optical, Medicine, Ophthalmology, Medical specialties, Dystrophy, Medical terminology, Clinical medicine, Eye surgery, Fuchs' dystrophy, Corneal opacity

The "Corneal Endothelial Dystrophy (CED) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Corneal Endothelial Dystrophy (CED) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.
  • This 'Corneal Endothelial Dystrophy (CED) - Epidemiology Forecast - 2030' report delivers an in-depth understanding of the Corneal Endothelial Dystrophy, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The Corneal Endothelial Dystrophy epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries.
  • The disease epidemiology covered in the report provides historical as well as forecasted Corneal Endothelial Dystrophy symptoms epidemiology segmented as the Total Prevalent cases of Corneal Endothelial Dystrophy, Gender-specific cases of Corneal Endothelial Dystrophy, Age-specific cases of Corneal Endothelial Dystrophy, and Type-specific cases of Corneal Endothelial Dystrophy.

Oxford Finance Closes $60 Million Credit Facility with RxSight

Retrieved on: 
Martedì, Dicembre 1, 2020
Technology, Medical devices, Surgery, Medical Supplies, Finance, Professional services, Biotechnology, Hardware, Health, Optical, Ophthalmology, Eye surgery, Anatomy, Medical specialties, Vision, Eye, Cataract surgery, Lenses, Cataract, Oxford Finance LLC, RxSight, Inc.

The RxSight Light Adjustable Lens delivers superior visual outcomespatients can now customize their vision after cataract surgery until it meets their personal desires and lifestyle requirements.

Key Points: 
  • The RxSight Light Adjustable Lens delivers superior visual outcomespatients can now customize their vision after cataract surgery until it meets their personal desires and lifestyle requirements.
  • RxSights proprietary Light Adjustable Lens offers an invaluable advancement in the cataract surgery market, said Christopher A. Herr, senior managing director at Oxford Finance.
  • Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide.
  • In recent years, Oxford has originated over $6 billion in loans, with lines of credit ranging from $5 million to $150 million.

Alcon Canada introduces AcrySof IQ Vivity, the only presbyopia-correcting intraocular lens with X-WAVE technology

Retrieved on: 
Martedì, Novembre 17, 2020
Medical specialties, Clinical medicine, Eye surgery, Medicine, Vision, Ophthalmology, Corrective lenses, Eye, Intraocular lens, Lens, Presbyopia, IOL

According to patient-reported outcomes, the AcrySof IQ Vivity lens enables high-quality vision at far and intermediate ranges as well as functional up-close vision.

Key Points: 
  • According to patient-reported outcomes, the AcrySof IQ Vivity lens enables high-quality vision at far and intermediate ranges as well as functional up-close vision.
  • Recent clinical trials found AcrySof IQ Vivity provides excellent distance vision quality and intermediate ranges in bright and dim light.
  • We have the #1 presbyopia-correcting lens in Canada with AcrySof IQ PanOptix and we believe AcrySof IQ Vivity will be a complimentary lens expanding vision correction options to Canadian patients.
  • The non-diffractive AcrySof IQ Vivity Extended Vision Posterior Chamber Intraocular Lens Model DFT015 (referred to as AcrySof IQ Vivity IOL) is a UV-absorbing and blue light filtering foldable intraocular lens (IOL).

EyePoint Pharmaceuticals Presents Positive Data of YUTIQ® and DEXYCU® in Four Poster Sessions at the American Academy of Ophthalmology 2020 Virtual Annual Meeting

Retrieved on: 
Lunedì, Novembre 16, 2020
Organ systems, Medical specialties, Chemical compounds, Cataract surgery, Eye surgery, Lenses, Cataract, Dexamethasone, Bromfenac

Data from a multicenter retrospective study of real-world usage of DEXYCU which demonstrated significant inflammatory reduction post-cataract surgery.

Key Points: 
  • Data from a multicenter retrospective study of real-world usage of DEXYCU which demonstrated significant inflammatory reduction post-cataract surgery.
  • At 36 months, the recurrence rate in YUTIQ-treated eyes was significantly lower than in sham-treated eyes (46.5% vs. 75.0%, respectively; p=0.001).
  • Pain was significantly reduced in the DEXYCU and Prolensa treatment group compared to a full post-operative eye drop treatment regimen.
  • Each time point of data in the real-world study reflects patient chart data and frequency of measurement by participating physicians.